Skip to content

Disc Medicine IRON Shares (Basic)

Shares (Basic) at other companies

Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
254.1M-1.1%
Protagonist Therapeutics logo
Protagonist TherapeuticsPTGX
65.1M+3.4%
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
58.8M+2.3%
Beam Therapeutics logo
Beam TherapeuticsBEAM
103.3M+17.4%
Travere Therapeutics, Inc. logo
Travere Therapeutics, Inc.TVTX
91.9M+4.0%
BridgeBio Pharma logo
BridgeBio PharmaBBIO
194.8M+2.4%

Other financials

Income statement

See full
Operating income-$69.5M-74.0%
Net income-$63.5M-86.3%
EPS (diluted)-$1.65-61.8%

Balance sheet

See full
Cash & equivalents$88.9M-27.5%
Total debt$31.1M+1.4%
Total equity$688.4M+4.3%
Total assets$750.2M+5.8%

Cash flow

See full
Operating cash flow-$62.2M-50.4%
CapEx--100%
Free cash flow-$62.2M-47.4%

Valuation

See full
Market cap$2.69B+42.2%
Enterprise value$2.63B+46.7%

Returns & leverage

See full
Return on equity-35.8%+41.3pp
Debt / equity0.0×
Current ratio24×-13.6×

Where this comes from

Reported directly by Disc Medicine in its filing.

Tagged under the XBRL concept us-gaap:WeightedAverageNumberOfSharesOutstandingBasic.

The official record: Disc Medicine’s 10-Q, filed May 5, 2026, on SEC EDGAR. View the filing →

Ask your AI about Disc Medicine's shares (basic).

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Disc Medicine's shares (basic)?
Disc Medicine (IRON) reported shares (basic) of 38.5M in Q1 2026.
How has Disc Medicine's shares (basic) changed year-over-year?
Disc Medicine's shares (basic) increased by 15.5% year-over-year, from 33.3M to 38.5M.
What is the long-term trend for Disc Medicine's shares (basic)?
Over 3 years (2022 to 2025), Disc Medicine's shares (basic) has grown at a 229.8% compound annual growth rate (CAGR), from 3.9M to 138.8M.
What does shares (basic) mean?
The time-weighted average number of common shares outstanding during the period, used as the denominator for basic EPS calculations.